Lifeline Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2009	FY 2004	FY 2003	FY 2002
Period Ending	Dec '09 Dec 31, 2009	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002
Cash & Equivalents	0.6	0.18	0.24	-
Cash & Short-Term Investments	0.6	0.18	0.24	-
Cash Growth	232.89%	-25.54%	-	-
Other Receivables	-	-	0.56	-
Receivables	-	-	0.56	-
Inventory	-	0.22	-	-
Prepaid Expenses	-	0	0.06	-
Total Current Assets	0.6	0.4	0.86	-
Property, Plant & Equipment	0.05	0.09	0.11	-
Long-Term Investments	5	-	-	-
Other Intangible Assets	0.14	0.13	0.06	-
Long-Term Deferred Charges	0.12	-	-	-
Other Long-Term Assets	0.81	0.06	0.01	-
Total Assets	6.72	0.69	1.04	-
Accounts Payable	0.01	0.15	0.18	-
Accrued Expenses	0.03	-	-	-
Current Portion of Long-Term Debt	0.03	-	-	-
Total Current Liabilities	0.07	0.15	0.18	-
Long-Term Debt	0.45	0.94	0.19	-
Other Long-Term Liabilities	0.1	-	-	-
Total Liabilities	0.62	1.09	0.38	-
Common Stock	0.03	0.02	0.01	-
Additional Paid-In Capital	18.25	10.99	10.33	-
Retained Earnings	-12.17	-11.41	-9.67	-
Total Common Equity	6.11	-0.41	0.66	-
Shareholders' Equity	6.11	-0.4	0.67	-
Total Liabilities & Equity	6.72	0.69	1.04	-
Total Debt	0.48	0.94	0.19	-
Net Cash (Debt)	0.12	-0.76	0.05	-
Net Cash Per Share	0.00	-	-	-
Filing Date Shares Outstanding	2,913	-	-	-
Total Common Shares Outstanding	2,913	-	-	-
Working Capital	0.53	0.25	0.68	-
Book Value Per Share	0.00	-	-	-
Tangible Book Value	5.96	-0.54	0.6	-
Tangible Book Value Per Share	0.00	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.